The UK regulator has licensed Sun Pharma's Leqselvi for severe alopecia areata, but NICE still has to rule on NHS funding, a process that has already rejected one rival drug and nearly rejected another.
A one-minute daily stretching routine is said to tone and slim, but the "slimming" part relies on spot reduction, a mechanism exercise science has repeatedly found doesn't work.
A Vogue España write-up praises Haruharu Wonder's Rose PDRN serum as a "100% natural" night fix, but doesn't say which of two differently formulated serums it means, or that PDRN's regenerative evidence comes almost entirely from injectables, not jars.
"Dead butt syndrome" describes a real muscle-inhibition process from sitting, but the name itself has almost no footing in peer-reviewed literature. Here is what the evidence actually supports, and what it does not.
Source class, response status, anonymity, uncertainty, corrections, and update trails determine how strongly a conclusion can travel.
Source Desk
The widely cited claim that genitourinary syndrome of menopause affects 84% of women comes from the top of a 13-87% evidence range, not a settled rate, and under-diagnosis, not prevalence, is the better-documented problem.
Spacing out shampoos to calm dandruff often backfires: French dermatology guidance says the fix is the right active shampoo on a tapering schedule, not simply washing less.
Liver and shellfish top the B12 charts, but food tables disagree wildly on the numbers, and the real risk for many people comes from metformin or age, not diet.
A meta-analysis of 29 trials found omega-3 supplements modestly reduced aggression in children and adults, but the widely shared "up to 28%" figure overstates what is a small-to-medium effect.
Oura, Apple and Whoop all added menopause tracking in 2026, but no major wearable brand has published a clinical trial validating its sensors for perimenopause, and Apple's temperature sensor still can't detect hot flashes on its own.
A self-test can tell you how an IV vitamin drip felt, not whether it boosted immunity. Reviews, German regulators and consumer testers find no proven benefit for healthy adults, plus real risks.
A new meta-analysis found B vitamins tracked with eased autism symptoms and vitamin D with better attention in ADHD, but the data is pooled from small, uneven trials. Here is what the evidence actually supports, and where it stops.
A UF study tying glucosamine to a 25% higher dementia progression risk covers only sick patients in retrospective records, and contradicts a larger, healthy-population UK Biobank study that found glucosamine lowers dementia risk.
Glucosamine, chondroitin and collagen for joint pain carry no EU-approved health claim, and ANSES has warned diabetics, asthmatics and anyone on blood thinners against them. Here is what the evidence, the regulators and a 2025 fraud sweep actually show.
Which? tested 26 menopause supplements and found over 80 active ingredients, often underdosed, while calcium was missing from 20 of them and vitamin D from six.
Roundups crown magnesium glycinate or threonate as the "best" sleep supplement, but the 2025 systematic review behind those claims rates the evidence low to very low, and the pricier forms have the thinnest trial data of all.
About 20% of GLP-1 users report hair shedding, but no randomized trial has confirmed the link, so doctors are leaning on physiology and patient surveys instead.
Evidence backs targeted vitamin D courses for over-75s, pregnant women and people with malabsorption, not routine dosing for healthy adults. The Endocrine Society's 2024 guideline and the 2022 VITAL fracture trial explain why blanket autumn "cures" outpace the data.
